{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T03:23:10Z","timestamp":1784517790832,"version":"3.55.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Governance Research Institute"},{"name":"Waseda chronicle"},{"name":"Ain Pharmaciez Inc"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0239610","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T17:48:00Z","timestamp":1602611280000},"page":"e0239610","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":37,"title":["Pharmaceutical company payments to dermatology Clinical Practice Guideline authors in Japan"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4279-4748","authenticated-orcid":true,"given":"Anju","family":"Murayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Sawano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kana","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"issue":"8","key":"pone.0239610.ref001","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1001\/jamainternmed.2016.2765","article-title":"Pharmaceutical Industry-Sponsored Meals and Physician Prescribing Patterns for Medicare Beneficiaries","volume":"176","author":"C DeJong","year":"2016","journal-title":"JAMA Intern Med"},{"key":"pone.0239610.ref002","doi-asserted-by":"crossref","first-page":"l6015","DOI":"10.1136\/bmj.l6015","article-title":"Association between gifts from pharmaceutical companies to French general practitioners and their drug prescribing patterns in 2016: retrospective study using the French Transparency in Healthcare and National Health Data System databases","volume":"367","author":"B Goupil","year":"2019","journal-title":"BMJ"},{"issue":"5","key":"pone.0239610.ref003","doi-asserted-by":"crossref","first-page":"e193817","DOI":"10.1001\/jamanetworkopen.2019.3817","article-title":"Payments From Pharmaceutical Companies to Authors Involved in the Valsartan Scandal in Japan","volume":"2","author":"T Sawano","year":"2019","journal-title":"JAMA Netw Open"},{"key":"pone.0239610.ref004","unstructured":"Japan Pharmaceutical Manufacturers Association. Transparency guideline for the relation between corporate activities and medical institutions [in Japanese] 2018 [cited 2019 December 14]. Available from: http:\/\/www.jpma.or.jp\/english\/policies_guidelines\/transparency_guideline.html."},{"issue":"4","key":"pone.0239610.ref005","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/jamainternmed.2018.7283","article-title":"Pharmaceutical Company Payments to Executive Board Members of Professional Medical Associations in Japan","volume":"179","author":"H Saito","year":"2019","journal-title":"JAMA Intern Med"},{"key":"pone.0239610.ref006","volume-title":"Clinical Practice Guidelines We Can Trust","author":"Institute of Medicine","year":"2011"},{"key":"pone.0239610.ref007","doi-asserted-by":"crossref","first-page":"g6003","DOI":"10.1136\/bmj.g6003","article-title":"Open Payments goes live with pharma to doctor fee data: first analysis","volume":"349","author":"D Jarvies","year":"2014","journal-title":"BMJ"},{"issue":"11","key":"pone.0239610.ref008","doi-asserted-by":"crossref","first-page":"e1000128","DOI":"10.1371\/journal.pmed.1000128","article-title":"Mandatory disclosure of pharmaceutical industry-funded events for health professionalsPubMed Central PMCID: PMC2764857.","volume":"6","author":"J Robertson","year":"2009","journal-title":"PLoS Med"},{"issue":"5","key":"pone.0239610.ref009","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.healthpol.2018.03.015","article-title":"Decoding disclosure: Comparing conflict of interest policy among the United States, France, and Australia","volume":"122","author":"Q Grundy","year":"2018","journal-title":"Health Policy"},{"issue":"4","key":"pone.0239610.ref010","doi-asserted-by":"crossref","first-page":"e192834","DOI":"10.1001\/jamanetworkopen.2019.2834","article-title":"Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan","volume":"2","author":"H Saito","year":"2019","journal-title":"JAMA Netw Open"},{"key":"pone.0239610.ref011","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.trci.2019.05.003","article-title":"Pharmaceutical company payments to the authors of the Japanese dementia clinical practice guidelines in 2016","volume":"5","author":"Y Shimada","year":"2019","journal-title":"Alzheimers Dement (N Y)"},{"issue":"12","key":"pone.0239610.ref012","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/jamadermatol.2017.3109","article-title":"Evaluating Industry Payments Among Dermatology Clinical Practice Guidelines Authors","volume":"153","author":"JX Checketts","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"9","key":"pone.0239610.ref013","doi-asserted-by":"crossref","first-page":"e028805","DOI":"10.1136\/bmjopen-2018-028805","article-title":"Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis","volume":"9","author":"A Ozaki","year":"2019","journal-title":"BMJ Open"},{"key":"pone.0239610.ref014","unstructured":"Japanese Dermatology Association. Policy of Conflict of Interest in Medical Research [in Japanese]: Japanese Dermatology Association,; 2018 [cited 2019 December 26]. Available from: https:\/\/www.dermatol.or.jp\/uploads\/uploads\/files\/about\/coi\/20180601_1.pdf."},{"issue":"9","key":"pone.0239610.ref015","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.2106\/JBJS.19.01005","article-title":"Pharmaceutical Company Payments to the Professors of Orthopaedic Surgery Departments in Japan","volume":"102","author":"H Saito","year":"2020","journal-title":"JBJS"},{"issue":"3","key":"pone.0239610.ref016","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jamainternmed.2017.7445","article-title":"Types and Distributions of Biomedical Industry Payments to Men and Women Physicians by Specialty, 2015","volume":"178","author":"KR Tringale","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"17","key":"pone.0239610.ref017","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1001\/jama.2017.3091","article-title":"Types and Distribution of Payments From Industry to Physicians in 2015","volume":"317","author":"KR Tringale","year":"2017","journal-title":"JAMA"},{"key":"pone.0239610.ref018","unstructured":"Ministry of Health LaW. Survey of Physicians, Dentists and Pharmacists 2018. Ministry of Health, Labour and Welfare; 2018."},{"issue":"2","key":"pone.0239610.ref019","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.healthpol.2011.07.012","article-title":"The working status of Japanese female physicians by area of practice: Cohort analysis of taking leave, returning to work, and changing specialties from 1984 to 2004","volume":"105","author":"T Kodama","year":"2012","journal-title":"Health Policy"},{"issue":"8","key":"pone.0239610.ref020","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3109\/0142159X.2013.786173","article-title":"Gender inequality in academic medicine in Japan","volume":"35","author":"K. Yasukawa","year":"2013","journal-title":"Medical Teacher"},{"issue":"3","key":"pone.0239610.ref021","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1620\/tjem.234.221","article-title":"Gender Inequality in Career Advancement for Females in Japanese Academic Surgery","volume":"234","author":"K Okoshi","year":"2014","journal-title":"The Tohoku Journal of Experimental Medicine"},{"issue":"10179","key":"pone.0239610.ref022","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/S0140-6736(18)33180-5","article-title":"Entrance examination misogyny in Japanese medical schools","volume":"393","author":"K Oshima","year":"2019","journal-title":"The Lancet"},{"issue":"10","key":"pone.0239610.ref023","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/jamainternmed.2017.3437","article-title":"Hours Worked Among US Dual Physician Couples With Children, 2000 to 2015","volume":"177","author":"DP Ly","year":"2017","journal-title":"JAMA Intern Med"},{"key":"pone.0239610.ref024","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.3685110","volume-title":"Gender Gap in Science in Japan: Graduate School of Public Policy","author":"S Shibayama","year":"2016"},{"issue":"9","key":"pone.0239610.ref025","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.socscimed.2012.07.014","article-title":"Impact of gender-based career obstacles on the working status of women physicians in Japan","volume":"75","author":"K Nomura","year":"2012","journal-title":"Social Science & Medicine"},{"key":"pone.0239610.ref026","unstructured":"American Academy of Dermatology. DISCLOSURE OF OUTSIDE INTERESTS AND MANAGEMENT OF CONFLICTS OF INTEREST [cited 2019 December 31]. Available from: https:\/\/coi.aad.org\/Regulation.aspx."},{"issue":"4","key":"pone.0239610.ref027","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1056\/NEJMp068282","article-title":"Guidance for Guidelines","volume":"356","author":"R. Steinbrook","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"pone.0239610.ref028","volume-title":"Disclosure of Conflicts of Interest Principles, Policies & Procedures for Managing Conflicts of Interest American Urological Association","author":"American Urological Association","year":"2018"},{"key":"pone.0239610.ref029","unstructured":"\u201cMoney for Docs\u201d database [Internet]. Waseda Chronicle the Medical Governance Research Institute. 2020. Available from: https:\/\/db.wasedachronicle.org\/."},{"key":"pone.0239610.ref030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.urology.2020.02.022","article-title":"Strong Conflict of Interest Policies are not Associated With Decreased Industry Payments to Academic Urology Departments","volume":"140","author":"J Bandari","year":"2020","journal-title":"Urology"},{"key":"pone.0239610.ref031","doi-asserted-by":"crossref","first-page":"m769","DOI":"10.1136\/bmj.m769","article-title":"Is it time to nationalise the pharmaceutical industry?","volume":"368","author":"M Mazzucato","year":"2020","journal-title":"BMJ"},{"issue":"12","key":"pone.0239610.ref032","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jamadermatol.2016.3037","article-title":"Exploring the Industry-Dermatologist Financial Relationship: Insight From the Open Payment Data","volume":"152","author":"H Feng","year":"2016","journal-title":"JAMA Dermatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0239610","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T04:07:04Z","timestamp":1669176424000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0239610"}},"subtitle":[],"editor":[{"given":"Tim","family":"Mathes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":32,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0239610","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,13]]}}}